Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Other-Current-Liabilities" stands at 610.63 Billion Japanese Yens as of 06/30/2025.
As of the end of Astellas Pharma Inc.'s first quarter, the item "Other Current Liabilities" stands at 610.63 Billion JPY. This represents an increase of 0.56 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -2.52 percent compared to the value the year prior.
The 1 year change in percent is -2.52.
The 3 year change in percent is 7.23.
The 5 year change in percent is 21.43.
The 10 year change in percent is 230.71.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Current Liabilities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Current Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Current Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Current Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Current Liabilities | 280,205,508,085.11 |